Menu
Not yet recruiting NCT07412548

Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients

No phase Interventional Chronic Kidney Disease Stage V End-Stage Renal Disease Hemodialysis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy, listening to dangdut music.
Who it may be relevant to
Registry conditions: Chronic Kidney Disease Stage V, End-Stage Renal Disease, Hemodialysis. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Indonesia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effectiveness of Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy on Anxiety, Sleep Quality, and Hemodynamic Parameters in Hemodialysis Patients

Overview

This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.

Detailed description

This study applies a quasi-experimental pretest-posttest control group design. The intervention group receives structured autogenic relaxation followed by Surah Ar-Rahman murottal therapy for 10-15 minutes per session, twice weekly for six weeks. The control group receives standard hemodialysis care with music listening. Anxiety, sleep quality, and hemodynamic parameters are assessed before and after the intervention.

Interventions

  • Behavioral Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy
    A structured non-pharmacological intervention consisting of autogenic relaxation techniques including breathing regulation, muscle relaxation, and self-suggestion, followed by listening to Surah Ar-Rahman murottal recitation using earphones. Each session lasts 10-15 minutes and is conducted twice weekly for six weeks during routine hemodialysis.
  • Other listening to dangdut music
    listening to dangdut music for 10 to 15 minutes within 6 weeks

Primary outcome measures

  • Anxiety [Time frame: Baseline and after completion of the 6-week intervention]
  • Sleep Quality [Time frame: Baseline and after completion of the 6-week intervention.]
  • Blood Presure [Time frame: Baseline and after completion of the 6-week intervention]
  • Heart Rate [Time frame: Baseline and after completion of the 6-week intervention]

Eligibility criteria

Inclusion criteria

  • Patients diagnosed with stage V chronic kidney disease.
  • Undergoing scheduled hemodialysis at least twice a week for 6 weeks.
  • Outpatients and aged 18-65 years.
  • Muslim.
  • Cooperative and able to communicate verbally.
  • Willing to be a respondent by signing an informed consent form.

Exclusion criteria

  • Having a severe heart condition or an unstable critical condition.
  • Having a severe psychiatric disorder (schizophrenia, major depression).
  • Having a cognitive, hearing, or speech disorder that impedes communication.
  • Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Indonesia · 1 center
  • Indriati Hospital — Sukoharjo

Identifiers

NCT: NCT07412548 · UMS-HD-ARMR-2026-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗